TH
AZN icon

Timber Hill’s AstraZeneca AZN Stock Holding History

Timber Hill’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,450
Closed -$3.14M – 1003
2017
Q1 		$3.14M Buy
50,450
+21,300
+73% +$1.24M 0.02% 512
2016
Q4 		$1.59M Buy
29,150
+11,850
+68% +$673K 0.01% 1020
2016
Q3 		$1.14M Sell
17,300
-36,700
-68% -$2.4M 0.01% 1059
2016
Q2 		$3.26M Buy
54,000
+32,350
+149% +$1.88M 0.02% 675
2016
Q1 		$1.22M Buy
21,650
+12,800
+145% +$769K 0.01% 1167
2015
Q4 		$601K Sell
8,850
-67,600
-88% -$4.43M ﹤0.01% 1613
2015
Q3 		$4.87M Sell
76,450
-188,050
-71% -$12.4M 0.02% 572
2015
Q2 		$16.9M Buy
264,500
+193,600
+273% +$13.3M 0.08% 229
2015
Q1 		$4.85M Buy
70,900
+18,900
+36% +$1.31M 0.02% 601
2014
Q4 		$3.66M Sell
52,000
-13,300
-20% -$952K 0.01% 691
2014
Q3 		$4.67M Sell
65,300
-23,900
-27% -$1.75M 0.02% 640
2014
Q2 		$6.63M Buy
89,200
+44,900
+101% +$3.25M 0.03% 495
2014
Q1 		$2.87M Buy
44,300
+21,400
+93% +$1.38M 0.01% 932
2013
Q4 		$1.36M Sell
22,900
-9,700
-30% -$527K ﹤0.01% 1627
2013
Q3 		$1.69M Sell
32,600
-128,900
-80% -$6.47M 0.01% 1570
2013
Q2 		$7.64M Buy
+161,500
New +$8.22M 0.03% 582

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Timber Hill's AZN Position: Q4 2017 in Review

Timber Hill sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 3,956 shares — an estimated $268K sold.

Timber Hill first reported a position in AZN in Q3 2013 and held it in 14 quarters. The position peaked at $6.32M in Q2 2014. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Timber Hill reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • Timber Hill sold 3,956 AstraZeneca shares in Q4 2017, an estimated $268K.
  • Timber Hill first reported a position in AstraZeneca in Q3 2013 and held it in 14 quarters.
  • Timber Hill's AstraZeneca position peaked at $6.32M in Q2 2014.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.